Michael Barbella, Managing Editor03.28.24
Theragenics Corporation has named Mark Pugh as CEO, succeeding Frank Tarallo, who retired after a decade of leadership.
Pugh has more than 20 years of medical device industry expertise and boasts a proven track record of driving strategic expansion and growth. His most recent role at Theragenics was president of the OEM Group, where he oversaw the company's design and contract manufacturing services and its subsidiaries—Arrotek Medical, Galt Medical, and NeedleTech. Notably, Pugh co-founded Arrotek Medical, a medical device design consultancy specializing in minimally invasive devices. Under his leadership, Arrotek grew from a two-person startup in Sligo, Ireland, to a thriving global enterprise with more than 100 employees and has assisted over 250 companies to develop their own medical devices. Arrotek Medical was acquired by Theragenics in 2019.
"I am passionate about Theragenics' mission of delivering life-changing minimally invasive medical solutions," Pugh stated. "This company possesses a robust foundation and a diversified portfolio of capabilities across multiple growing therapeutic areas. I am thrilled to collaborate with our leadership team and Board of Directors to propel Theragenics to new heights, cultivate a culture of innovation, optimize operational efficiencies, and ultimately enhance the value we deliver to our customers, clinicians, and most importantly, the patients we serve."
Theragenics delivers life-changing medical solutions. Pioneers in the field of brachytherapy, the company offers minimally invasive, radiation-based treatments for prostate and other cancers. Through its subsidiaries the firm designs and delivers a diverse portfolio of vascular access, specialty needles products, and surgical devices, serving critical needs across interventional radiology, interventional cardiology, and vascular surgery.
Pugh has more than 20 years of medical device industry expertise and boasts a proven track record of driving strategic expansion and growth. His most recent role at Theragenics was president of the OEM Group, where he oversaw the company's design and contract manufacturing services and its subsidiaries—Arrotek Medical, Galt Medical, and NeedleTech. Notably, Pugh co-founded Arrotek Medical, a medical device design consultancy specializing in minimally invasive devices. Under his leadership, Arrotek grew from a two-person startup in Sligo, Ireland, to a thriving global enterprise with more than 100 employees and has assisted over 250 companies to develop their own medical devices. Arrotek Medical was acquired by Theragenics in 2019.
"I am passionate about Theragenics' mission of delivering life-changing minimally invasive medical solutions," Pugh stated. "This company possesses a robust foundation and a diversified portfolio of capabilities across multiple growing therapeutic areas. I am thrilled to collaborate with our leadership team and Board of Directors to propel Theragenics to new heights, cultivate a culture of innovation, optimize operational efficiencies, and ultimately enhance the value we deliver to our customers, clinicians, and most importantly, the patients we serve."
Theragenics delivers life-changing medical solutions. Pioneers in the field of brachytherapy, the company offers minimally invasive, radiation-based treatments for prostate and other cancers. Through its subsidiaries the firm designs and delivers a diverse portfolio of vascular access, specialty needles products, and surgical devices, serving critical needs across interventional radiology, interventional cardiology, and vascular surgery.